Loss of the Malignant Phenotype of Human Neuroblastoma Cells by a Catalytically Inactive Dominant-Negative hTERT MutantMona Samy(Université Paris-Sud), E. Segal(University of Tennessee at Knoxville)Molecular Cancer TherapeuticsAugust 29, 201210.1158/1535-7163.mct-12-0281Cited by 16SaveCiteExport RISWatch citationsRelated PapershTERT DNA Methylation Analysis Identifies a Biomarker for Retinoic Acid-Induced hTERT Repression in Breast Cancer Cell Lines|Biomedicines|2022|8